Provider
Vasomotor Symptoms (formerly Neurokinin Receptor Antagonists) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2024
Documents & Forms Results
Displaying 811 - 820 of 3159 results
Provider
Resmetirom - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2024
Provider
Dry Eye Disease - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2024
Provider
Furoscix® (furosemide) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2024
Provider
Furoscix® (furosemide) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2024
Provider
Ryplazim® (plasminogen,human-tvmh) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2024
Provider
Ryplazim® (plasminogen,human-tvmh) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2024
Provider
Antifungals - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2024
Provider
Opzelura™ (ruxolitinib) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Dec 01, 2024
Provider
Carbaglu® (carglumic acid) - Commercial
Prior Authorization
Program effective Date: Dec 01, 2024